Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
eye disease
Biotech
Opus sets sights on FDA talks after posting gene therapy data
Opus Genetics shared data on its gene therapy in kids with an ultrarare eye disease, setting the biotech up to talk to the FDA about the next steps.
Nick Paul Taylor
Sep 30, 2025 9:15am
Eye disease biotech launches with $100M, Roche rival in clinic
Sep 17, 2025 6:30am
Opthea ramps up cuts to 85% of staff, including CEO
Aug 19, 2025 7:35am
Boehringer inks another eye disease deal, this time with Palatin
Aug 18, 2025 10:30am
Roche axes Carmot obesity asset, 3 cancer drugs in R&D clear-out
Jul 24, 2025 5:00am
Cloudbreak plots phase 3 after eye drop passes midstage test
Jul 21, 2025 4:35am